Larry Jones Receives Son’s Kidney, Competes at 2026 Transplant Games

Larry Jones, an end-stage kidney disease patient who had lost more than 90% of his kidney function, received a kidney from his son Macoy in May 2023 — and this week, DaVita Newsroom reports he marked his recovery by competing at the 2026 Transplant Games of America in Denver.

The story is a human one, but it sits inside a business with hard economics attached: the national kidney waitlist now exceeds 90,000 Americans, and DaVita Inc. (NYSE: DVA) — the dialysis giant behind the care team that guided the Jones family — operates at the center of that demand.

The numbers that turn a feel-good story into a market story. Larry Jones learned he had less than 10% of kidney function, transitioned quickly to dialysis, and faced the standard path for most patients: a deceased-donor waitlist measured in years.

DaVita Newsroom says kidneys from living donors typically work 12 to 20 years on average and can sharply shorten the wait. Every living-donor transplant like the Jones family’s removes one patient from dialysis rolls — the revenue base on which DaVita depends, and the cost line that Medicare, the dominant payer for dialysis, manages most closely.

Living-donor kidneys outlast deceased-donor organs

  • More than 90,000 Americans are waiting for a kidney on the national waitlist, per DaVita Newsroom — demand that structurally outpaces deceased-donor supply.
  • Living-donor kidneys last an average of 12–20 years, longer than deceased-donor organs, shifting long-term cost away from dialysis toward transplantation.
  • Paired kidney exchange and transplant chains now connect incompatible donor pairs, widening the donor pool beyond biological matches like the Jones family.

Son considers donating kidney to father

“I knew I was getting older and slowing down a bit, but I thought I was well,” Larry Jones remembers. “Then I got the actual diagnosis of having less than 10% of kidney function,” Jones said.

Former BYU athletic director receives kidney donation from his son

After the end-stage diagnosis, dialysis sustained him while a transplant offered the best path forward. The turning point came in a conversation about the deceased-donor list. “I was listening to the social worker [discussing getting on the deceased donor list] and just had an idea,” Macoy Jones told DaVita Newsroom. “He’s my father, maybe I’m a match.”

With guidance from DaVita’s care team and social workers, father and son went through the evaluation and donation process together. In May 2023, the transplant was completed.

From Kidney Failure to Transplant Games — FOX59 News

Why living donation moves the dialysis economics

But the balance-sheet logic runs in the opposite direction from the waitlist logic. Dialysis is a recurring, revenue-generating treatment; a successful transplant ends it. For the roughly 90,000 patients on the waitlist, each living-donor transplant shortens the queue for those who remain — and for payers, a graft functioning 12 to 20 years replaces years of per-treatment reimbursement with a one-time surgical event and lower-cost follow-up care.

That is why transplant chains and paired exchange programs matter commercially as well as clinically: they convert incompatible pairs, like a donor who isn’t a biological match, into viable transplants across the country, expanding volume in a supply-constrained market.

Davita’s own framing of the case leans on that clinical advantage. The company points patients toward the living-donation experience and publishes myth-correction material from its social workers, including living donor Angela Laino, as part of the education push that produced the Jones family’s outcome.

Key figure Value Source context
Americans on kidney waitlist More than 90,000 DaVita Newsroom, national waitlist
Living-donor kidney function 12–20 years average DaVita Newsroom, vs. shorter deceased-donor function
Larry Jones kidney function at diagnosis Less than 10% DaVita Newsroom, at end-stage diagnosis
Years between father’s gift and son’s 31 Larry Jones, on his son’s donation

Life after the transplant

Today Larry is active and mentoring other kidney patients. At the 2026 Transplant Games of America in Denver, he competed on the basketball court and celebrated on the dance floor.

“It means an awful lot for me to be able to give my father the gift of life,” Macoy says. “I think I would have been robbed of seeing him in his older age and how he is compared to how he was when I was a kid.”

Larry put the exchange in his own ledger. “It’s amazing that my son became my living donor. I gave him life and 31 years later he gave me my life back,” he says.

What the Jones case signals for the transplant market

The takeaway for observers of the dialysis and transplant sector: education and paired-exchange infrastructure are where the marginal transplants come from. Every patient like Larry Jones who moves from the waitlist to a living-donor graft represents demand satisfied years earlier than the deceased-donor queue would allow — and one fewer long-term dialysis patient.

Disclaimer: The information provided in this article is for educational and informational purposes only and does not constitute financial advice.

Photo of author

Newsroom

Newsroom at Archyde.

Genetic “Dimmer Switch” Explains Disease Severity in Rare Muscular Dystrophy